The complexity of clinical trials often discourages potential participants, but a clearer understanding of how they work could help fill a critical gap in medical research. According to a study by the Crohn’s & Colitis Foundation, nearly 1 in 100 Americans has inflammatory bowel disease (IBD), a group of conditions including Crohn’s disease and ulcerative colitis that cause intestinal inflammation and sometimes complications throughout the body. Research into these conditions has the potential to change lives, yet many trials face delays due to lack of enrollment. “We need more people to get involved in clinical trials, especially those from underrepresented communities, including people of color and older adults, who have some of the highest rates of chronic disease,” said Dr. Ruby Greywoode, a gastroenterologist at Montefiore Medical Center.
Clinical trials can take many forms, from medication studies to investigations of diet or emotional impact. Each trial is typically divided into four phases that build on each other. Phase 1 asks whether a drug is safe, testing it in a small group of healthy people to determine dosage and side effects. Phase 2 asks whether it is effective, giving the drug to a larger group with the condition—for example, 100 people with IBD—and comparing different dosages or placebos. Phase 3 asks whether it works better than currently available treatments, expanding to more participants over a longer period; if results are strong, the company may submit an application to the FDA. Phase 4 monitors the drug’s real-world effects after approval, often following thousands of patients for years.
For the millions living with IBD in the U.S., clinical trials offer hope for more treatments, less pain and healthier lives. That is why the Crohn’s & Colitis Foundation aims to make trials less mysterious and more accessible. The foundation encourages patients to talk with their healthcare professionals about whether a trial is right for them and to explore opportunities at CrohnsColitisFoundation.org. For those interested in IBD trials, the foundation provides a searchable resource at crohnscolitisfoundation.org/clinical-trials-community. “Clinical trials give patients a real way to shape the future of treatment,” Greywoode said. “It’s not just about their own care; it can help others, too.”


